Launched on December 20, 2011, the VanEck Biotech ETF (BBH) is a passively managed exchange-traded fund. BBH provides broad exposure to the Healthcare - Biotech segment of the equity market, aimed at investors seeking sector-specific biotech exposure via an ETF structure.
Launched on December 20, 2011, the VanEck Biotech ETF (BBH) is a passively managed exchange-traded fund. BBH provides broad exposure to the Healthcare - Biotech segment of the equity market, aimed at investors seeking sector-specific biotech exposure via an ETF structure.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.00
